Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
Haley Mudrick(Mayo Clinic), Brian J. Parrett(Mayo Clinic), Jack R. Hemsath(Mayo Clinic in Arizona), Shane Massey(The University of Texas Medical Branch at Galveston), Gloria Olivier(Mayo Clinic), Madiha Fida(Mayo Clinic), Aleksandra Drelich(The University of Texas Medical Branch at Galveston), Michael J. Hansen(Mayo Clinic), Chisom Uzendu(Mayo Clinic), Gina A. Suh(European Society of Clinical Microbiology and Infectious Diseases), Virginia P. Van Keulen(Mayo Clinic), Courtney L. Erskine(Mayo Clinic), Michael A. Barry(Mayo Clinic), Erin B. McGlinch(Mayo Clinic), Joseph A. Panos(Mayo Clinic in Florida), Chien‐Te K. Tseng(The University of Texas Medical Branch at Galveston), Jeffrey D. Rubin(Mayo Clinic), Tobias Peikert(Mayo Clinic in Arizona), Matthew S. Block(Mayo Clinic in Arizona), Mary E. Barry(Mayo Clinic)
Cited by 16
Related Papers
Animal models for COVID-19
|Nature|2020|877
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer
|Journal of Biomedical Optics|2007|220
Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
|PLoS ONE|2010|213
Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting
|Current Gene Therapy|2007|207